Tamoxifen Market Size, Share, Growth, Strategies, Segmentation and Forecast 2017 – 2025: Brisk Insights

According to a recently published report by Brisk Insights, the Global Tamoxifen Market is expected to grow at the CAGR of 0.6% during 2017-2025. The global tamoxifen market is segmented on the basis of applications and geography. The report on global tamoxifen market forecast 2017-2025 (by applications, and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Tamoxifen Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/tamoxifen-market

Market Insights

Tamoxifen is among the oldest and most prescribed antagonist of the estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is an approved drug for metastatic hormone-receptor positive breast cancer, and to reduce the risk of recurrence after surgery and chemotherapy. Women at a high risk of developing breast cancer are also advised to take tamoxifen. Other uses of tamoxifen include treatment of ductal carcinoma, McCune-Albright syndrome, Gynecomastia, Infertility and Riedel’s Thyroiditis. Efficacy of hormone therapy for management and treatment of breast cancer across the different stages of treatment, and extensive use of tamoxifen as adjuvant therapy are the key factors diving the demand of tamoxifen market. However, growth of tamoxifen-resistant cancer and introduction of drug inducing endometrial cancer may act as a market growth barrier during the forecast period. Currently, North America held the pole position in the global tamoxifen market and shall dominate the market throughout the forecast period. Large patient base of breast cancer, growing awareness regarding cancer screening and prevention, well organized healthcare infrastructure and reimbursement scenario are the factors assisting the growth of tamoxifen market in North America. Asia-Pacific is expected to experience the fastest growth during the forecast period. High incidence of late stage breast cancer in the regions and rapid development of healthcare infrastructure are the prime drivers of the growth of tamoxifen market in Asia-Pacific.

Browse here for all category Reports : http://www.briskinsights.com/category/pharmaceutical-industry

Scope of the report

1. Global Tamoxifen Market, by Application, 2015-2025 ($ Million)

1.1. Breast Cancer
1.2. McCune-Albright syndrome
1.3. Gynecomastia
1.4. Others (Infertility, Gene Expression, Riedel’s Thyroiditis)

2. Global Tamoxifen Market, by Geography, 2015-2025 ($ Million)

2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Latin America (LATAM)
2.5. Middle East and Africa (MEA)

3. Profiles

3.1. AstraZeneca plc
3.2. Allergan plc
3.3. Teva Pharmaceuticals Industries Ltd.
3.4. Apotex, Inc.
3.5. Mylan Pharmaceuticals, Inc.
3.6. Watson laboratories Inc.
3.7. Aegis pharmaceuticals Inc.
3.8. Others

Download Free Request Sample : http://www.briskinsights.com/sample-request/577

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)
Email : [email protected]
Website : http://www.briskinsights.com/

Leave a Reply

Your email address will not be published. Required fields are marked *